CTS PSC Cryomedium:
 Provides efficient recovery and higher viability than traditional methods of PSC cryopreservation
 Facilitates regulatory filings through cGMP manufacturing and the availability of documentation
 Simplifies the transition from bench to clinic through the direct replacement of RUO PSC Cryopreservation Medium

Efficient recovery:
CTS PSC Cryomedium routinely achieves higher viability than traditional methods of cryopreservation and is compatible with clump and single cell passaged PSCs cultured in a variety of media systems. CTS PSC Cryomedium is provided as a ready-to-use, complete solution containing 10% DMSO for efficient cell addition. Separate additions of enhancing reagents are not required, helping save valuable preparation time.

Facilitates regulatory filings:
CTS PSC Cryomedium is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS PSC Cryomedium.

Simplifies transition from bench to clinic:
With its extensive safety testing, including adventitious agents, CTS PSC Cryomedium enables a smooth transition from RUO PSC Cryopreservation Medium.